Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Kidney Calculi | 49 | 2023 | 469 | 10.920 |
Why?
|
Ureteral Calculi | 28 | 2024 | 117 | 9.970 |
Why?
|
Ureteroscopy | 36 | 2024 | 150 | 8.420 |
Why?
|
Nephrolithiasis | 24 | 2024 | 117 | 7.480 |
Why?
|
Nephrostomy, Percutaneous | 16 | 2023 | 79 | 5.170 |
Why?
|
Ureter | 16 | 2023 | 370 | 4.500 |
Why?
|
Lithotripsy | 14 | 2023 | 141 | 4.350 |
Why?
|
Urolithiasis | 17 | 2023 | 125 | 4.050 |
Why?
|
Renal Colic | 6 | 2020 | 29 | 2.510 |
Why?
|
Urinary Tract Infections | 8 | 2024 | 805 | 1.750 |
Why?
|
Kidney Pelvis | 5 | 2024 | 195 | 1.730 |
Why?
|
Lithotripsy, Laser | 8 | 2023 | 45 | 1.640 |
Why?
|
Urinary Calculi | 9 | 2021 | 90 | 1.520 |
Why?
|
Ureteral Neoplasms | 7 | 2023 | 108 | 1.480 |
Why?
|
Ureteroscopes | 2 | 2022 | 22 | 1.480 |
Why?
|
Calcium Oxalate | 8 | 2023 | 75 | 1.470 |
Why?
|
Citric Acid | 6 | 2015 | 124 | 1.210 |
Why?
|
Cystinuria | 3 | 2024 | 22 | 1.090 |
Why?
|
Ureteral Obstruction | 5 | 2017 | 297 | 1.080 |
Why?
|
Urology | 6 | 2024 | 411 | 1.020 |
Why?
|
Stents | 11 | 2023 | 3200 | 1.010 |
Why?
|
Urine | 4 | 2012 | 362 | 1.010 |
Why?
|
Sepsis | 7 | 2024 | 2609 | 1.010 |
Why?
|
Urologic Diseases | 2 | 2019 | 247 | 0.980 |
Why?
|
Hydronephrosis | 3 | 2016 | 274 | 0.940 |
Why?
|
Kidney Medulla | 3 | 2015 | 169 | 0.890 |
Why?
|
Carcinoma, Transitional Cell | 6 | 2023 | 798 | 0.760 |
Why?
|
Thiazides | 2 | 2013 | 19 | 0.750 |
Why?
|
Calcium | 5 | 2015 | 5792 | 0.690 |
Why?
|
Potassium Citrate | 2 | 2018 | 8 | 0.680 |
Why?
|
Lasers, Solid-State | 5 | 2023 | 183 | 0.660 |
Why?
|
Decision Support Techniques | 5 | 2016 | 2008 | 0.650 |
Why?
|
Disposable Equipment | 1 | 2019 | 46 | 0.650 |
Why?
|
Shock, Septic | 2 | 2023 | 774 | 0.630 |
Why?
|
Retrospective Studies | 59 | 2024 | 81892 | 0.620 |
Why?
|
Tomography, X-Ray Computed | 24 | 2023 | 20776 | 0.600 |
Why?
|
Endoscopy | 5 | 2020 | 1862 | 0.590 |
Why?
|
Kidney Neoplasms | 11 | 2023 | 4300 | 0.580 |
Why?
|
Hydrodynamics | 1 | 2018 | 167 | 0.580 |
Why?
|
Humans | 158 | 2024 | 768887 | 0.560 |
Why?
|
Flank Pain | 1 | 2016 | 44 | 0.510 |
Why?
|
Calcium Phosphates | 2 | 2018 | 173 | 0.510 |
Why?
|
Hyperoxaluria | 2 | 2012 | 33 | 0.510 |
Why?
|
Antacids | 1 | 2015 | 94 | 0.500 |
Why?
|
Analgesics, Opioid | 3 | 2021 | 3837 | 0.500 |
Why?
|
Device Removal | 3 | 2021 | 643 | 0.490 |
Why?
|
Ureteral Diseases | 3 | 2013 | 63 | 0.480 |
Why?
|
Pressure | 3 | 2024 | 1172 | 0.470 |
Why?
|
Asymptomatic Diseases | 1 | 2017 | 590 | 0.460 |
Why?
|
Obesity, Morbid | 2 | 2016 | 1300 | 0.450 |
Why?
|
Female | 92 | 2024 | 397464 | 0.450 |
Why?
|
Dehydration | 1 | 2015 | 216 | 0.440 |
Why?
|
Male | 89 | 2024 | 365249 | 0.440 |
Why?
|
Urinary Bladder Neoplasms | 5 | 2023 | 2250 | 0.440 |
Why?
|
Nutrition Surveys | 3 | 2019 | 1738 | 0.430 |
Why?
|
Citrates | 2 | 2011 | 134 | 0.430 |
Why?
|
Radiography, Dual-Energy Scanned Projection | 3 | 2022 | 209 | 0.420 |
Why?
|
Circadian Rhythm | 4 | 2012 | 2593 | 0.410 |
Why?
|
Nomograms | 1 | 2014 | 236 | 0.410 |
Why?
|
Kidney Diseases | 4 | 2011 | 2100 | 0.410 |
Why?
|
Middle Aged | 64 | 2024 | 223740 | 0.400 |
Why?
|
Carbonated Beverages | 2 | 2011 | 210 | 0.400 |
Why?
|
Postoperative Care | 3 | 2015 | 1481 | 0.400 |
Why?
|
Comprehension | 1 | 2018 | 639 | 0.400 |
Why?
|
Prescription Drugs | 1 | 2019 | 635 | 0.390 |
Why?
|
Neutrophils | 1 | 2024 | 3785 | 0.390 |
Why?
|
Kidney Tubules | 1 | 2013 | 454 | 0.380 |
Why?
|
Allopurinol | 1 | 2013 | 202 | 0.380 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2015 | 2297 | 0.370 |
Why?
|
Sodium | 3 | 2015 | 1597 | 0.370 |
Why?
|
Swine | 5 | 2024 | 5998 | 0.370 |
Why?
|
Vasectomy | 2 | 2017 | 52 | 0.360 |
Why?
|
Malates | 1 | 2010 | 35 | 0.350 |
Why?
|
Urinalysis | 6 | 2012 | 370 | 0.350 |
Why?
|
Alkalies | 1 | 2010 | 45 | 0.350 |
Why?
|
Obesity, Abdominal | 1 | 2013 | 375 | 0.350 |
Why?
|
Laparoscopy | 6 | 2013 | 2055 | 0.350 |
Why?
|
Radiation Dosage | 7 | 2023 | 1970 | 0.350 |
Why?
|
Body Mass Index | 3 | 2016 | 13054 | 0.340 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 7 | 2019 | 1232 | 0.340 |
Why?
|
Kidney Calices | 1 | 2009 | 26 | 0.340 |
Why?
|
Oxalates | 1 | 2010 | 99 | 0.340 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 3233 | 0.340 |
Why?
|
Urogenital Neoplasms | 2 | 2009 | 132 | 0.340 |
Why?
|
Kidney | 7 | 2022 | 7057 | 0.340 |
Why?
|
Hyperparathyroidism, Primary | 2 | 2009 | 164 | 0.340 |
Why?
|
Obstetric Labor Complications | 1 | 2012 | 242 | 0.330 |
Why?
|
Drug Prescriptions | 1 | 2019 | 1673 | 0.330 |
Why?
|
Subcutaneous Fat, Abdominal | 1 | 2010 | 91 | 0.330 |
Why?
|
Urologic Surgical Procedures | 4 | 2017 | 299 | 0.330 |
Why?
|
Chyle | 1 | 2009 | 17 | 0.330 |
Why?
|
Colic | 1 | 2009 | 44 | 0.330 |
Why?
|
Radiation Protection | 3 | 2013 | 428 | 0.330 |
Why?
|
Robotics | 3 | 2013 | 826 | 0.320 |
Why?
|
Treatment Outcome | 25 | 2023 | 65485 | 0.320 |
Why?
|
Ultrasonography | 4 | 2017 | 6001 | 0.310 |
Why?
|
Magnesium | 1 | 2012 | 816 | 0.310 |
Why?
|
Emergency Service, Hospital | 5 | 2023 | 7956 | 0.310 |
Why?
|
Adult | 52 | 2024 | 223818 | 0.300 |
Why?
|
Pain Measurement | 3 | 2016 | 3585 | 0.300 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 2009 | 124 | 0.300 |
Why?
|
Fistula | 1 | 2009 | 213 | 0.290 |
Why?
|
Aged | 45 | 2024 | 171790 | 0.280 |
Why?
|
Foreign-Body Migration | 1 | 2009 | 220 | 0.280 |
Why?
|
Prostatectomy | 2 | 2013 | 1841 | 0.280 |
Why?
|
Mesenchymoma | 1 | 2006 | 50 | 0.270 |
Why?
|
Disease Models, Animal | 2 | 2024 | 18366 | 0.270 |
Why?
|
Therapeutic Irrigation | 2 | 2024 | 297 | 0.270 |
Why?
|
Health Services Accessibility | 1 | 2024 | 5520 | 0.260 |
Why?
|
Seasons | 1 | 2012 | 1523 | 0.260 |
Why?
|
Diet | 2 | 2015 | 8090 | 0.250 |
Why?
|
Internet | 1 | 2018 | 3112 | 0.250 |
Why?
|
Beverages | 1 | 2011 | 819 | 0.250 |
Why?
|
Escherichia coli Infections | 2 | 2024 | 524 | 0.250 |
Why?
|
Penile Neoplasms | 1 | 2006 | 158 | 0.240 |
Why?
|
Guideline Adherence | 1 | 2015 | 2240 | 0.240 |
Why?
|
Laser Therapy | 2 | 2023 | 1110 | 0.230 |
Why?
|
Prevalence | 7 | 2024 | 15875 | 0.230 |
Why?
|
Risk Assessment | 8 | 2024 | 24330 | 0.230 |
Why?
|
Vas Deferens | 1 | 2004 | 55 | 0.230 |
Why?
|
Erythrocytes | 1 | 2013 | 2421 | 0.230 |
Why?
|
Oligospermia | 1 | 2004 | 59 | 0.230 |
Why?
|
Cystine | 2 | 2024 | 96 | 0.230 |
Why?
|
Postoperative Complications | 7 | 2019 | 15889 | 0.220 |
Why?
|
Vitamins | 1 | 2012 | 1638 | 0.220 |
Why?
|
Internship and Residency | 2 | 2024 | 5956 | 0.220 |
Why?
|
Catheters, Indwelling | 1 | 2006 | 436 | 0.220 |
Why?
|
Anti-Bacterial Agents | 4 | 2018 | 7472 | 0.220 |
Why?
|
Sperm Count | 1 | 2004 | 229 | 0.210 |
Why?
|
Glomerular Filtration Rate | 1 | 2012 | 2228 | 0.210 |
Why?
|
Foreign Medical Graduates | 1 | 2024 | 77 | 0.210 |
Why?
|
Tulipa | 1 | 2022 | 1 | 0.210 |
Why?
|
Diabetic Nephropathies | 1 | 2010 | 973 | 0.210 |
Why?
|
Hydrogen-Ion Concentration | 4 | 2023 | 2488 | 0.210 |
Why?
|
Eponyms | 1 | 2002 | 14 | 0.210 |
Why?
|
Prosthesis Failure | 2 | 2021 | 1209 | 0.210 |
Why?
|
Recurrence | 6 | 2015 | 8512 | 0.210 |
Why?
|
Oxidative Stress | 1 | 2013 | 3138 | 0.200 |
Why?
|
Cholinergic Antagonists | 1 | 2023 | 167 | 0.200 |
Why?
|
Embryology | 1 | 2002 | 30 | 0.200 |
Why?
|
Lymphocyte Count | 1 | 2024 | 793 | 0.200 |
Why?
|
Achievement | 1 | 2024 | 288 | 0.200 |
Why?
|
Mitomycin | 4 | 2023 | 262 | 0.200 |
Why?
|
Antibiotic Prophylaxis | 2 | 2018 | 640 | 0.190 |
Why?
|
Platelet Count | 1 | 2024 | 787 | 0.190 |
Why?
|
Kidney Failure, Chronic | 1 | 2014 | 2493 | 0.190 |
Why?
|
Uric Acid | 4 | 2023 | 806 | 0.190 |
Why?
|
C-Reactive Protein | 1 | 2013 | 3858 | 0.190 |
Why?
|
Equipment Design | 4 | 2012 | 3529 | 0.190 |
Why?
|
Pelvic Neoplasms | 1 | 2023 | 250 | 0.190 |
Why?
|
Hypercalciuria | 2 | 2012 | 31 | 0.180 |
Why?
|
Leukocyte Count | 1 | 2024 | 1609 | 0.180 |
Why?
|
Systemic Inflammatory Response Syndrome | 2 | 2023 | 621 | 0.170 |
Why?
|
Sex Characteristics | 1 | 2010 | 2660 | 0.170 |
Why?
|
Carcinoma, Renal Cell | 3 | 2010 | 3200 | 0.170 |
Why?
|
Multivariate Analysis | 5 | 2021 | 12093 | 0.160 |
Why?
|
Nephrology | 1 | 2002 | 270 | 0.150 |
Why?
|
Factitious Disorders | 1 | 2018 | 39 | 0.150 |
Why?
|
Models, Statistical | 3 | 2013 | 5107 | 0.150 |
Why?
|
Vitamin D | 1 | 2012 | 3311 | 0.150 |
Why?
|
Young Adult | 16 | 2021 | 60110 | 0.150 |
Why?
|
Risk Factors | 13 | 2021 | 74971 | 0.150 |
Why?
|
Heterozygote | 1 | 2024 | 2798 | 0.140 |
Why?
|
Prostatic Neoplasms | 3 | 2017 | 11229 | 0.140 |
Why?
|
Diabetes Mellitus | 2 | 2015 | 5892 | 0.140 |
Why?
|
Lymph Nodes | 1 | 2009 | 3473 | 0.140 |
Why?
|
Narcotics | 1 | 2019 | 334 | 0.140 |
Why?
|
Urinary Tract | 1 | 2020 | 305 | 0.140 |
Why?
|
Diagnostic Imaging | 1 | 2011 | 3538 | 0.140 |
Why?
|
Nanoparticles | 1 | 2009 | 1989 | 0.140 |
Why?
|
Lymphocytes | 1 | 2024 | 2614 | 0.130 |
Why?
|
Incidence | 8 | 2021 | 21545 | 0.130 |
Why?
|
Consensus | 3 | 2022 | 3214 | 0.130 |
Why?
|
Follow-Up Studies | 10 | 2020 | 39394 | 0.130 |
Why?
|
Body Size | 1 | 2019 | 463 | 0.130 |
Why?
|
Aged, 80 and over | 15 | 2021 | 59738 | 0.130 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2019 | 703 | 0.120 |
Why?
|
Constriction, Pathologic | 3 | 2023 | 1104 | 0.120 |
Why?
|
Vasodilator Agents | 1 | 2019 | 990 | 0.120 |
Why?
|
Bayes Theorem | 1 | 2023 | 2357 | 0.120 |
Why?
|
Radiographic Image Enhancement | 2 | 2010 | 877 | 0.120 |
Why?
|
ROC Curve | 1 | 2023 | 3629 | 0.120 |
Why?
|
Holmium | 3 | 2023 | 29 | 0.120 |
Why?
|
Muscle Contraction | 1 | 2019 | 1209 | 0.120 |
Why?
|
Lasers | 2 | 2009 | 952 | 0.120 |
Why?
|
Cost-Benefit Analysis | 4 | 2016 | 5544 | 0.120 |
Why?
|
Animals | 9 | 2024 | 169408 | 0.110 |
Why?
|
Kallikreins | 1 | 2015 | 219 | 0.110 |
Why?
|
Hypertension | 2 | 2015 | 8615 | 0.110 |
Why?
|
Intensive Care Units | 3 | 2023 | 3800 | 0.110 |
Why?
|
Urease | 1 | 2013 | 43 | 0.110 |
Why?
|
Self Report | 3 | 2021 | 3773 | 0.100 |
Why?
|
Urologic Neoplasms | 1 | 2016 | 318 | 0.100 |
Why?
|
Time Factors | 10 | 2021 | 40266 | 0.100 |
Why?
|
Ureterolithiasis | 1 | 2012 | 1 | 0.100 |
Why?
|
Sex Distribution | 2 | 2015 | 2280 | 0.100 |
Why?
|
Predictive Value of Tests | 4 | 2016 | 15471 | 0.100 |
Why?
|
Thulium | 2 | 2023 | 21 | 0.100 |
Why?
|
Urography | 2 | 2013 | 316 | 0.100 |
Why?
|
Hospital Mortality | 2 | 2023 | 5369 | 0.100 |
Why?
|
Severity of Illness Index | 5 | 2015 | 15955 | 0.100 |
Why?
|
Magnetic Resonance Imaging | 2 | 2010 | 36861 | 0.100 |
Why?
|
Citrus sinensis | 1 | 2011 | 15 | 0.100 |
Why?
|
Diagnosis, Differential | 3 | 2016 | 13020 | 0.090 |
Why?
|
United States | 6 | 2023 | 73180 | 0.090 |
Why?
|
Prospective Studies | 11 | 2023 | 54950 | 0.090 |
Why?
|
Potassium | 1 | 2015 | 1319 | 0.090 |
Why?
|
Benchmarking | 1 | 2018 | 1058 | 0.090 |
Why?
|
Linear Models | 2 | 2012 | 5890 | 0.090 |
Why?
|
Humidity | 1 | 2012 | 207 | 0.090 |
Why?
|
Intestinal Absorption | 1 | 2012 | 400 | 0.090 |
Why?
|
Prognosis | 5 | 2023 | 30044 | 0.090 |
Why?
|
Nephrocalcinosis | 1 | 2011 | 51 | 0.090 |
Why?
|
Rupture, Spontaneous | 1 | 2011 | 365 | 0.090 |
Why?
|
Technetium Tc 99m Mertiatide | 1 | 2010 | 21 | 0.090 |
Why?
|
Pain, Postoperative | 1 | 2021 | 1765 | 0.090 |
Why?
|
Postoperative Period | 3 | 2023 | 1830 | 0.090 |
Why?
|
Nephrogenic Fibrosing Dermopathy | 1 | 2010 | 42 | 0.090 |
Why?
|
Cohort Studies | 4 | 2024 | 41800 | 0.090 |
Why?
|
Radiopharmaceuticals | 2 | 2010 | 2734 | 0.090 |
Why?
|
Nephrectomy | 3 | 2010 | 949 | 0.090 |
Why?
|
Diet Therapy | 1 | 2011 | 150 | 0.080 |
Why?
|
Supine Position | 2 | 2020 | 208 | 0.080 |
Why?
|
International Cooperation | 1 | 2016 | 1436 | 0.080 |
Why?
|
Myocardial Revascularization | 1 | 2013 | 796 | 0.080 |
Why?
|
Cardiovascular Diseases | 1 | 2015 | 15662 | 0.080 |
Why?
|
Cystoscopy | 1 | 2009 | 132 | 0.080 |
Why?
|
Academic Medical Centers | 2 | 2010 | 2784 | 0.080 |
Why?
|
Health Personnel | 1 | 2023 | 3382 | 0.080 |
Why?
|
Calcium, Dietary | 1 | 2012 | 533 | 0.080 |
Why?
|
Sex Factors | 3 | 2018 | 10641 | 0.080 |
Why?
|
Quality of Life | 5 | 2023 | 13510 | 0.080 |
Why?
|
Tomography, Spiral Computed | 1 | 2010 | 274 | 0.080 |
Why?
|
Ureterostomy | 1 | 2008 | 18 | 0.080 |
Why?
|
Pain | 1 | 2023 | 5100 | 0.070 |
Why?
|
Probability | 2 | 2010 | 2483 | 0.070 |
Why?
|
Lymphatic Diseases | 1 | 2009 | 319 | 0.070 |
Why?
|
Urinary Catheterization | 1 | 2008 | 195 | 0.070 |
Why?
|
Vascular System Injuries | 1 | 2011 | 248 | 0.070 |
Why?
|
Prostate-Specific Antigen | 2 | 2015 | 2487 | 0.070 |
Why?
|
Calcinosis | 1 | 2015 | 1481 | 0.070 |
Why?
|
Parathyroidectomy | 1 | 2009 | 244 | 0.070 |
Why?
|
Obesity | 3 | 2020 | 13087 | 0.070 |
Why?
|
Standard of Care | 1 | 2011 | 570 | 0.070 |
Why?
|
Confidence Intervals | 1 | 2012 | 2931 | 0.070 |
Why?
|
Intraoperative Care | 2 | 2015 | 771 | 0.070 |
Why?
|
Urologic Surgical Procedures, Male | 1 | 2006 | 79 | 0.070 |
Why?
|
Adolescent | 10 | 2021 | 89247 | 0.070 |
Why?
|
Arteriovenous Malformations | 1 | 2009 | 396 | 0.070 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2010 | 12252 | 0.060 |
Why?
|
Patient Care Planning | 1 | 2011 | 904 | 0.060 |
Why?
|
Catheter Ablation | 2 | 2010 | 2780 | 0.060 |
Why?
|
Age Factors | 3 | 2017 | 18454 | 0.060 |
Why?
|
Child | 7 | 2018 | 80969 | 0.060 |
Why?
|
Temperature | 1 | 2012 | 2235 | 0.060 |
Why?
|
Fluoroscopy | 1 | 2009 | 947 | 0.060 |
Why?
|
Sodium, Dietary | 1 | 2009 | 426 | 0.060 |
Why?
|
Logistic Models | 3 | 2015 | 13317 | 0.060 |
Why?
|
Models, Anatomic | 1 | 2009 | 683 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2023 | 5375 | 0.060 |
Why?
|
Gadolinium | 1 | 2010 | 965 | 0.060 |
Why?
|
Cryosurgery | 1 | 2010 | 477 | 0.060 |
Why?
|
Amino Acid Transport Systems, Basic | 1 | 2024 | 35 | 0.060 |
Why?
|
Suture Techniques | 1 | 2010 | 779 | 0.060 |
Why?
|
Amino Acid Transport System y+ | 1 | 2024 | 40 | 0.060 |
Why?
|
Amino Acid Transport Systems, Neutral | 1 | 2024 | 42 | 0.060 |
Why?
|
Medicare | 1 | 2023 | 6888 | 0.060 |
Why?
|
Early Detection of Cancer | 2 | 2017 | 3238 | 0.060 |
Why?
|
Remission Induction | 1 | 2010 | 2411 | 0.060 |
Why?
|
Ultrasonography, Doppler | 1 | 2006 | 463 | 0.060 |
Why?
|
Cold Temperature | 1 | 2008 | 791 | 0.060 |
Why?
|
Mitomycins | 1 | 2023 | 46 | 0.060 |
Why?
|
Demography | 1 | 2008 | 1643 | 0.050 |
Why?
|
Carotid Stenosis | 1 | 2011 | 862 | 0.050 |
Why?
|
Absorptiometry, Photon | 1 | 2009 | 1757 | 0.050 |
Why?
|
Social Class | 1 | 2012 | 2009 | 0.050 |
Why?
|
Pilot Projects | 3 | 2018 | 8742 | 0.050 |
Why?
|
Radiography | 2 | 2015 | 6991 | 0.050 |
Why?
|
Hospitalization | 1 | 2023 | 10845 | 0.050 |
Why?
|
Societies, Medical | 1 | 2015 | 3967 | 0.050 |
Why?
|
Vitamin D Deficiency | 1 | 2012 | 1388 | 0.050 |
Why?
|
Models, Biological | 1 | 2018 | 9499 | 0.050 |
Why?
|
Enzyme Inhibitors | 1 | 2013 | 3724 | 0.050 |
Why?
|
Metabolic Diseases | 1 | 2009 | 684 | 0.050 |
Why?
|
Urinary Retention | 1 | 2003 | 107 | 0.050 |
Why?
|
Nephrons | 1 | 2023 | 168 | 0.050 |
Why?
|
History, 18th Century | 1 | 2002 | 206 | 0.050 |
Why?
|
Sodium Chloride | 1 | 2004 | 584 | 0.050 |
Why?
|
Insurance Coverage | 1 | 2013 | 1946 | 0.050 |
Why?
|
Semen | 1 | 2004 | 349 | 0.050 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2022 | 172 | 0.050 |
Why?
|
Feasibility Studies | 3 | 2022 | 5323 | 0.050 |
Why?
|
Urothelium | 1 | 2022 | 276 | 0.040 |
Why?
|
Poisson Distribution | 1 | 2021 | 508 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 3253 | 0.040 |
Why?
|
Germany | 1 | 2002 | 883 | 0.040 |
Why?
|
Angiogenesis Inhibitors | 1 | 2010 | 2059 | 0.040 |
Why?
|
History, 19th Century | 1 | 2002 | 715 | 0.040 |
Why?
|
Lymphoma, B-Cell | 1 | 2006 | 945 | 0.040 |
Why?
|
Technology | 1 | 2022 | 296 | 0.040 |
Why?
|
Phantoms, Imaging | 2 | 2022 | 2533 | 0.040 |
Why?
|
Nifedipine | 1 | 2019 | 220 | 0.040 |
Why?
|
Prone Position | 1 | 2020 | 203 | 0.040 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2003 | 365 | 0.040 |
Why?
|
Boston | 2 | 2009 | 9375 | 0.040 |
Why?
|
Escherichia coli | 1 | 2011 | 4212 | 0.040 |
Why?
|
Disease Management | 1 | 2009 | 2537 | 0.040 |
Why?
|
Prostatic Hyperplasia | 1 | 2003 | 523 | 0.040 |
Why?
|
Coronary Disease | 1 | 2013 | 5919 | 0.040 |
Why?
|
Contrast Media | 3 | 2019 | 5334 | 0.040 |
Why?
|
Delphi Technique | 1 | 2022 | 890 | 0.040 |
Why?
|
Sus scrofa | 1 | 2019 | 430 | 0.040 |
Why?
|
Genital Neoplasms, Female | 1 | 2003 | 538 | 0.040 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2003 | 1793 | 0.040 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2005 | 1093 | 0.040 |
Why?
|
Quality Improvement | 1 | 2013 | 3856 | 0.040 |
Why?
|
Patient Positioning | 1 | 2020 | 332 | 0.040 |
Why?
|
Adjuvants, Immunologic | 1 | 2022 | 999 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2012 | 14751 | 0.030 |
Why?
|
Smoking | 1 | 2013 | 9094 | 0.030 |
Why?
|
Glucose | 1 | 2008 | 4352 | 0.030 |
Why?
|
Regression Analysis | 2 | 2015 | 6346 | 0.030 |
Why?
|
Dietary Supplements | 1 | 2009 | 3442 | 0.030 |
Why?
|
Digital Rectal Examination | 1 | 2015 | 42 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2015 | 20244 | 0.030 |
Why?
|
Neoplasm Staging | 1 | 2010 | 11262 | 0.030 |
Why?
|
Statistics, Nonparametric | 2 | 2012 | 2862 | 0.030 |
Why?
|
Kidney Function Tests | 1 | 2017 | 684 | 0.030 |
Why?
|
Emergency Treatment | 1 | 2019 | 496 | 0.030 |
Why?
|
Atherosclerosis | 1 | 2011 | 3431 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2019 | 1339 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2023 | 3554 | 0.030 |
Why?
|
Child, Preschool | 4 | 2009 | 42684 | 0.030 |
Why?
|
Databases, Factual | 2 | 2018 | 8095 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2018 | 790 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 1 | 2023 | 6546 | 0.030 |
Why?
|
Myocardial Infarction | 1 | 2013 | 11521 | 0.030 |
Why?
|
Risk | 2 | 2015 | 9621 | 0.020 |
Why?
|
Outpatients | 1 | 2020 | 1604 | 0.020 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2013 | 198 | 0.020 |
Why?
|
Iopamidol | 1 | 2012 | 187 | 0.020 |
Why?
|
Patient Admission | 1 | 2019 | 1369 | 0.020 |
Why?
|
Creatinine | 1 | 2017 | 1917 | 0.020 |
Why?
|
Treatment Failure | 1 | 2017 | 2663 | 0.020 |
Why?
|
Biopsy, Needle | 2 | 2006 | 1627 | 0.020 |
Why?
|
Emergencies | 1 | 2017 | 1220 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2008 | 22294 | 0.020 |
Why?
|
Pregnancy | 1 | 2012 | 30175 | 0.020 |
Why?
|
Life Style | 1 | 2021 | 3931 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3903 | 0.020 |
Why?
|
Acute Disease | 1 | 2020 | 7245 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2008 | 9442 | 0.020 |
Why?
|
Subtraction Technique | 1 | 2012 | 519 | 0.020 |
Why?
|
Tensile Strength | 1 | 2010 | 335 | 0.020 |
Why?
|
Office Visits | 1 | 2013 | 596 | 0.020 |
Why?
|
CD-ROM | 1 | 2008 | 24 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7460 | 0.020 |
Why?
|
Alloys | 1 | 2008 | 111 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2014 | 2126 | 0.020 |
Why?
|
Reoperation | 2 | 2008 | 4342 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10115 | 0.020 |
Why?
|
Osteoporotic Fractures | 1 | 2012 | 417 | 0.020 |
Why?
|
England | 1 | 2008 | 533 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 3438 | 0.020 |
Why?
|
Syndrome | 1 | 2013 | 3274 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2010 | 1998 | 0.020 |
Why?
|
Surgical Instruments | 1 | 2008 | 385 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2015 | 2714 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2011 | 2108 | 0.020 |
Why?
|
Organ Size | 1 | 2010 | 2268 | 0.010 |
Why?
|
Infant | 1 | 2006 | 36541 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2019 | 19023 | 0.010 |
Why?
|
Biopsy | 1 | 2015 | 6805 | 0.010 |
Why?
|
Catheterization | 1 | 2009 | 1431 | 0.010 |
Why?
|
Perfusion | 1 | 2008 | 1402 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2019 | 5707 | 0.010 |
Why?
|
Age Distribution | 1 | 2009 | 2875 | 0.010 |
Why?
|
Neoplasm, Residual | 1 | 2008 | 1019 | 0.010 |
Why?
|
Intraoperative Period | 1 | 2003 | 513 | 0.010 |
Why?
|
Critical Care | 1 | 2015 | 2715 | 0.010 |
Why?
|
Libido | 1 | 2003 | 124 | 0.010 |
Why?
|
Image Enhancement | 1 | 2012 | 2898 | 0.010 |
Why?
|
Mass Screening | 1 | 2017 | 5455 | 0.010 |
Why?
|
Length of Stay | 1 | 2015 | 6525 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2005 | 1836 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 10397 | 0.010 |
Why?
|
Preoperative Care | 1 | 2009 | 2258 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2012 | 3709 | 0.010 |
Why?
|
Embolization, Therapeutic | 1 | 2009 | 1410 | 0.010 |
Why?
|
Erectile Dysfunction | 1 | 2003 | 445 | 0.010 |
Why?
|
Software | 1 | 2012 | 4480 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2005 | 21187 | 0.010 |
Why?
|
Mastectomy | 1 | 2005 | 1850 | 0.010 |
Why?
|
Algorithms | 1 | 2015 | 14199 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2011 | 14795 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2003 | 6242 | 0.010 |
Why?
|
Clinical Competence | 1 | 2010 | 4859 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2005 | 11119 | 0.010 |
Why?
|
Physicians | 1 | 2010 | 4607 | 0.010 |
Why?
|